Company / Debt per Share
Edwards Lifesciences Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.03
FY2025
5-year range
$0.95 / $1.03
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#89 of 98
Health Care
What the data says
Among 98 Health Care companies, Edwards Lifesciences is in the top 9% for debt per share. Debt per Share has increased for 5 consecutive years, from $0.95 in FY2020 to $1.03 in FY2025.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of +1.6%.
Increased from $0.98 to $1.03 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 98This company $1.03 Sector average $46.19
▼
-97.8% below sector average
Key checks
Key Insights
- Edwards Lifesciences's debt per share has grown for 5 consecutive years.
- In FY2025, debt per share increased 3.6% year-over-year.
- Ranks #89 out of 98 companies in the Health Care sector.
- Peak debt per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | +3.6% |
| FY2024 | $0.99 | +1.3% |
| FY2023 | $0.98 | +0.1% |
| FY2022 | $0.98 | +2.7% |
| FY2021 | $0.95 | +0.1% |
| FY2020 | $0.95 | -66.5% |
| FY2019 | $2.84 | -0.6% |
| FY2018 | $2.86 | +38.0% |
| FY2017 | $2.07 | -46.7% |
| FY2016 | $3.89 | -29.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026